| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.044 | 0.5 |